• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有注意力缺陷多动障碍(ADHD)、自闭症及精神疾病共病的瑞典青少年执行功能的行为表现:与社区对照组的比较分析

Behavioral manifestations of executive functioning in Swedish youth with ADHD, autism, and psychiatric comorbidity: a comparative analysis with community controls.

作者信息

Hamilton Annelie, Tallberg Pia, Ilahi Frida, Hoff Eva, Ahmadi Bahar, Daukantaitė Daiva

机构信息

Child and Adolescent, Psychiatric Clinic in Helsingborg, Helsingborg, Sweden.

Department of Psychology, Lund University, Lund, Sweden.

出版信息

Child Neuropsychol. 2025 Jul;31(5):771-790. doi: 10.1080/09297049.2024.2434736. Epub 2024 Dec 10.

DOI:10.1080/09297049.2024.2434736
PMID:39655647
Abstract

While several rating scales reliably and cost-effectively assess behavioral executive functioning (EF) in youths with neurodevelopmental disorders (NDDs), questions remain about the impact of comorbidities and dual NDDs on EF as measured by these scales in clinical samples. This study compared behavioral EF profiles among youths with NDDs, both with and without psychiatric comorbidities, non-NDDs (e.g. anxiety), and controls, as well as youths with single versus dual NDDs. The comparisons were made using the Swedish version of the Behavior Rating Inventory of Executive Function (BRIEF-2) parent form. Participants included 79 youths (mean [SD] age 12.1 [3.0]; 50.6% girls) diagnosed with various psychiatric conditions, and 151 matched controls (mean [SD] age 12.4 [2.8]; 51.7% girls). Results showed significant differences with very large effect sizes in all behavioral EF domains among youths with NDDs, regardless of whether they had non-NDD psychiatric comorbidities, compared to youths with non-NDDs or controls. The latter two groups differed in six of eight behavioral EF domains, with the Shift domain showing the largest effect size (Cohen's d = 0.94). Surprisingly, no significant differences were found between the NDD-only group and the NDD group with non-NDD psychiatric comorbidities. Youths with dual NDDs had more deficits in four of the nine behavioral EF domains compared to those with a single NDD, with the Shift domain again showing the largest effect size (Cohen's d = 0.91). This study highlights the essential role of NDD in distinguishing clinically significant parent-rated behavioral EF deficits in youths, regardless of other psychiatric diagnoses.

摘要

虽然有几种评定量表能够可靠且经济高效地评估神经发育障碍(NDD)青少年的行为执行功能(EF),但在临床样本中,这些量表所测量的共病和双重NDD对EF的影响仍存在疑问。本研究比较了患有NDD的青少年(有和没有精神共病)、非NDD(如焦虑症)青少年、对照组以及患有单一NDD与双重NDD的青少年之间的行为EF特征。使用执行功能行为评定量表(BRIEF - 2)瑞典语版的家长版进行比较。参与者包括79名被诊断患有各种精神疾病的青少年(平均[标准差]年龄12.1[3.0]岁;50.6%为女孩)和151名匹配的对照组(平均[标准差]年龄12.4[2.8]岁;51.7%为女孩)。结果显示,与非NDD青少年或对照组相比,患有NDD的青少年在所有行为EF领域均存在显著差异,效应量非常大,无论他们是否有非NDD精神共病。后两组在八个行为EF领域中的六个存在差异,其中转换领域的效应量最大(科恩d值 = 0.94)。令人惊讶的是,仅患有NDD的组与患有非NDD精神共病的NDD组之间未发现显著差异。与患有单一NDD的青少年相比,患有双重NDD的青少年在九个行为EF领域中的四个存在更多缺陷,转换领域的效应量再次最大(科恩d值 = 0.91)。本研究强调了NDD在区分青少年临床上具有显著意义的家长评定行为EF缺陷方面的重要作用,无论其他精神诊断如何。

相似文献

1
Behavioral manifestations of executive functioning in Swedish youth with ADHD, autism, and psychiatric comorbidity: a comparative analysis with community controls.患有注意力缺陷多动障碍(ADHD)、自闭症及精神疾病共病的瑞典青少年执行功能的行为表现:与社区对照组的比较分析
Child Neuropsychol. 2025 Jul;31(5):771-790. doi: 10.1080/09297049.2024.2434736. Epub 2024 Dec 10.
2
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
3
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
4
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.盐酸哌甲酯缓释片治疗成人注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD012857. doi: 10.1002/14651858.CD012857.pub2.
5
Unique and shared influences of anxiety and ADHD on the behavioral profile of autism in early childhood.焦虑症和注意力缺陷多动障碍对幼儿期自闭症行为特征的独特及共同影响。
Front Child Adolesc Psychiatry. 2025 Jun 5;4:1585507. doi: 10.3389/frcha.2025.1585507. eCollection 2025.
6
Memantine for autism spectrum disorder.美金刚治疗自闭症谱系障碍。
Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013845. doi: 10.1002/14651858.CD013845.pub2.
7
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.